Jamieson Wellness Inc. (OTCMKTS:JWLLF) Short Interest Update

Jamieson Wellness Inc. (OTCMKTS:JWLLF) saw a significant decline in short interest in August. As of August 14th, there was short interest totaling 94,875 shares, a decline of 76.6% from the July 30th total of 404,709 shares. Based on an average daily volume of 6,636 shares, the days-to-cover ratio is currently 14.3 days.

Jamieson Wellness Price Performance

OTCMKTS:JWLLF opened at $32.92 on Friday. The stock has a 50-day moving average price of $30.36 and a two-hundred day moving average price of $27.17. Jamieson Wellness has a 1 year low of $23.88 and a 1 year high of $33.15.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on JWLLF shares. National Bank Financial reissued an “outperform” rating on shares of Jamieson Wellness in a report on Friday, June 26th. Royal Bank Of Canada lowered Jamieson Wellness from an “outperform” rating to a “sector perform” rating in a research report on Monday, August 10th. Citigroup cut Jamieson Wellness to a “hold” rating in a research note on Friday, August 7th. Finally, Canadian Imperial Bank of Commerce reissued an “outperform” rating on shares of Jamieson Wellness in a report on Friday, May 8th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy”.

About Jamieson Wellness

Jamieson Wellness is a leading Canadian manufacturer and distributor of nutraceutical products, including vitamins, minerals, herbal remedies and dietary supplements. Founded in 1922, the company has grown to offer a diverse portfolio of formulations designed to support general health, immune function, digestion and other specialized wellness needs. Its flagship Jamieson brand is complemented by sub-brands such as bkind, reflecting a commitment to innovation and consumer choice across a range of tablet, capsule and gummy formats.

The company serves both domestic and international markets through a multi-channel approach that includes major mass and drug retailers, specialty stores and direct-to-consumer e-commerce platforms.